GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.74B
This Quarter Return
+5.57%
1 Year Return
+32.47%
3 Year Return
+84.41%
5 Year Return
–
10 Year Return
–
AUM
$838M
AUM Growth
+$838M
(+101%)
Cap. Flow
+$428M
Cap. Flow
% of AUM
51.08%
Top 10 Holdings %
Top 10 Hldgs %
41.74%
Holding
134
New
65
Increased
4
Reduced
8
Closed
15
Top Buys
| 1 |
Kenvue
KVUE
|
$58.1M |
| 2 |
GE HealthCare
GEHC
|
$40.6M |
| 3 |
PG&E
PCG
|
$34.6M |
| 4 |
RenaissanceRe
RNR
|
$28M |
| 5 |
NVIDIA
NVDA
|
$21.2M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$27.3M |
| 2 |
Charles Schwab
SCHW
|
$15.7M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$9.88M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
$9.84M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$7.97M |
Sector Composition
| 1 | Healthcare | 19.54% |
| 2 | Technology | 16.5% |
| 3 | Consumer Discretionary | 16.06% |
| 4 | Industrials | 10.26% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alphatec Holdings
ATEC
$2.33B
| $1.8M | 0.21% |
+100,000
| New | +$1.8M |
|
77
Bloom Energy
BE
$12.2B
| $1.64M | 0.2% |
100,000
| – | – |
|
78
iShares Silver Trust
SLV
$20.3B
| $1.61M | 0.19% |
77,000
-80,500
| -51% | -$1.68M |
|
79
Southwest Gas
SWX
$5.68B
| $1.59M | 0.19% |
25,000
| – | – |
|
|
HSAI
80
Hesai Group
HSAI
$3.49B
| $1.58M | 0.19% |
150,000
| – | – |
|
81
Terreno Realty
TRNO
$5.89B
| $1.5M | 0.18% |
25,000
| – | – |
|
|
SLRN
82
DELISTED
ACELYRIN
SLRN
| $1.46M | 0.17% |
+70,000
| New | +$1.46M |
|
|
SBDS
83
Solo Brands, Inc.
SBDS
$16.9M
| $1.42M | 0.17% |
+250,000
| New | +$1.42M |
|
84
Protagonist Therapeutics
PTGX
$3.6B
| $1.38M | 0.16% |
+50,000
| New | +$1.38M |
|
85
ATS Corp
ATS
$2.61B
| $1.24M | 0.15% |
+26,869
| New | +$1.24M |
|
86
Kura Sushi USA
KRUS
$1.03B
| $1.16M | 0.14% |
+12,500
| New | +$1.16M |
|
87
Kymera Therapeutics
KYMR
$3.03B
| $1.15M | 0.14% |
+50,000
| New | +$1.15M |
|
88
Lexicon Pharmaceuticals
LXRX
$396M
| $1.15M | 0.14% |
+500,000
| New | +$1.15M |
|
89
Verastem
VSTM
$560M
| $1.12M | 0.13% |
+150,000
| New | +$1.12M |
|
90
Kimbell Royalty Partners
KRP
$1.28B
| $1.1M | 0.13% |
75,000
| – | – |
|
|
ZING
91
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $1.08M | 0.13% |
103,550
-71,450
| -41% | -$745K |
|
92
Cactus
WHD
$2.74B
| $1.06M | 0.13% |
25,000
| – | – |
|
93
CureVac
CVAC
$1.21B
| $1.04M | 0.12% |
100,000
| – | – |
|
|
KLRS
94
Kalaris Therapeutics, Inc. Common Stock
KLRS
$77.6M
| $994K | 0.12% |
+292,316
| New | +$994K |
|
95
CorMedix
CRMD
$1.06B
| $991K | 0.12% |
+250,000
| New | +$991K |
|
96
EverCommerce
EVCM
$2.04B
| $888K | 0.11% |
75,000
| – | – |
|
97
Disc Medicine
IRON
$2.15B
| $888K | 0.11% |
+20,000
| New | +$888K |
|
98
IDEAYA Biosciences
IDYA
$2.25B
| $881K | 0.11% |
+37,500
| New | +$881K |
|
99
Atour Lifestyle Holdings
ATAT
$5.36B
| $812K | 0.1% |
+50,000
| New | +$812K |
|
100
Driven Brands
DRVN
$3.08B
| $677K | 0.08% |
25,000
| – | – |
|